University of Kentucky UK Markey Cancer Center

Lexington, Kentucky 40536

1 studies enrolling now · 4 studies all time

What they study most

Gastro-enteropancreatic Neuroendocrine Tumor, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Renal Cell Carcinoma

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET — Running, not enrolling
• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET — Running, not enrolling